ERGOMED Announces Launch of its Rare Disease Innovation Center


ERGOMED has announced the establishment of its Rare Disease Innovation Center™.

The Rare Disease Innovation Center™ is a consortium of innovative partners and internal subject matter experts dedicated to developing tailored solutions for rare disease-focused companies and patients.

In addition, ERGOMED has announced new partnerships with Trialbee and mdgroup as part of its new consortium. Trialbee will serve as its patient identification partner and mdgroup will provide patient support servces.

Read more about this announcement by following the links below:

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.